feedback

Activity Details

Free CME/CNE
1.25 AMA PRA Category 1 Credit(s)
1.25 Contact Hour(s)
Released: October 1, 2018
Expires: October 1, 2019
75 minutes to complete

Provider Statement

This continuing education activity is provided by

Support Statement

This continuing educational activity is supported by an educational grant from Aries Pharmaceuticals, Inc.

Activity Chair

(1) Latest Advances to Improve Polyp Resection
(2) Case Presentations

Douglas K. Rex, MD
Distinguished Professor of Medicine
Indiana University
Indianapolis, IN
Disclosures:
Consulting Fee: Aries Pharmaceuticals, Inc, Boston Scientific, Braintree, Cosmo Pharmaceuticals, Olympus
Contracted Research: Boston Scientific, Braintree, EndoAid Ltd, Medivators, Medtronic, Olympus, PAION, Sebela

Faculty

Increasing Adenoma Detection Rates: Improving Colorectal Cancer Outcomes
David A. Johnson, MD, MACG, FASGE, FACP
Professor of Medicine
Chief of Gastroenterology
Eastern Virginia Medical School
Norfolk, VA
Disclosures:
Consulting Fee: Aries Pharmaceuticals, Inc, CRH Medical, Pfizer, WebMD/Medscape


Tools and Devices to Improve Adenoma Detection Rates
Prateek Sharma, MD
Professor of Medicine
University of Kansas School of Medicine
Kansas City, MO
Disclosure: No relevant financial relationships to disclose.

Reviewer

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Disclosure: No relevant financial relationships to disclose.

Nurse Planners

Barbara A. Niedz, PhD, RN, CPHQ
Disclosure: No relevant financial relationships to disclose.

Kelli C. Kneisel, FNP
Disclosure: No relevant financial relationships to disclose.

Medical Writer

Valerie Zimmerman, PhD
Disclosure: No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Disclosures

In accordance with the Accreditation Council for Continuing Medical Education and the American Nurses Credentialing Center’s Standards for Commercial Support, all CME/CNE providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME/CNE content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the CME/CNE activity content over which the individual has control.

Unlabeled and Investigational Usage

The audience is advised that this continuing education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Accreditation

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Vindico Medical Education, LLC, is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Vindico Medical Education will provide 1.25 contact hours for nurses.

There is no non-commercial support for this activity.

Education activities are distinguished as separate from endorsement of commercial products. When commercial products are displayed, participants will be advised that accredited status as a provider refers only to its continuing education activities and does not imply ANCC Commission on Accreditation endorsement of any commercial products.

This enduring material is approved for 1 year from the date of original release, October 1, 2018 to October 1, 2019.

How to Participate in This Activity and Obtain CME/CNE Credit

To participate in this CME/CNE activity, you must answer the pre-activity questions, read the objectives and articles, and complete the post-activity questions and evaluation in their entirety. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 70% of the post-activity questions correctly. Upon receipt of the completed materials, if a satisfactory score on the post-activity is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ or Learner-Paced Contact Hours certificate immediately.

Overview

Colorectal cancer (CRC) is the third most common type of cancer worldwide and the second deadliest form of cancer in the United States. Studies on CRC screening show that for every 1% increase in a physician’s adenoma detection rate (ADR), the risk of colon cancer developing in their patients over the next year decreases by 3%. Thus, if physicians are proficient at finding and removing precancerous polyps during colonoscopy, cancer is less likely to develop. However, estimates suggest that up to 25% of adenomas are missed with current colonoscopy technologies, primarily due to poor visualization in folds and other difficult-to-detect areas. Modifiable factors to improve detection rates include colonoscopy team behaviors during procedures, endoscope design, and targeted education. Technological advances and strategies to improve visualization, as well as field of view, have improved detection rates in recent years, and more strategies are in development. In addition, when an adenoma is detected, the use of injectable solutions, such as artificial tears, hetastarch, or viscous agents with medium-chain triglycerides and methylene blue, may provide long-lasting submucosal lift and cushion to reduce the risk of perforation during removal. This educational activity will focus on strategies to improve polyp identification and reduce endoscopic resection risks.

Target Audience

This program is designed for gastroenterologists, nurses, and other health care professionals involved in the screening of patients for colorectal cancer (CRC).

Learning Objectives

Upon successful completion of this activity, participants should be better able to:
Physician Learning Objectives:

  • Examine trends in the incidence rates of CRC as well as the importance of appropriate screening and early detection.
  • Utilize appropriate strategies and devices to improve adenoma detection rates (ADR).
  • Identify polyps that may be better suited for endoscopic versus surgical removal.
  • Apply the latest technical advances to the resection of gastrointestinal polyps for cancer prevention.

Nurse Learning Objectives:

  • Examine trends in the incidence rates of CRC as well as the importance of appropriate screening and early detection.
  • Utilize appropriate strategies and devices to improve ADR.
  • Review the latest technical advances for the resection of gastrointestinal polyps for cancer prevention.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2018 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME Questions?

Contact us at CME@VindicoCME.com

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Start Activity

Select your specialty

You must select a specialty

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.